Empagliflozin Gets FDA Nod for CKD Without T2D or HF ...Middle East

Medscape - News
The US Food and Drug Administration gave the SGLT2 inhibitor empagliflozin (Jardiance) a new indication for treating adults with isolated chronic kidney disease. Medscape Medical News

Hence then, the article about empagliflozin gets fda nod for ckd without t2d or hf was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Empagliflozin Gets FDA Nod for CKD Without T2D or HF )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News